Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 57, Issue 6, 1997, Pages 551-554

  Jarrahian, A ^a   Hillard, C J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID; DIHYDROPYRIDINE DERIVATIVE; FATTY ACID DERIVATIVE; ISRADIPINE; NIMODIPINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN MEMBRANE; CONTROLLED STUDY; FOREBRAIN; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030827460     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90559-7     Document Type: Article

References (17)

1. Bachur N. R., Masek K, Melmon K. L., Udenfriend S. Fatty acid amides of ethanolamine in mammalian tissues. J Biol Chem 1965; 240: 1019-1024.
2. Schmid H. H. O., Schmid P. C., Natarajan V. N-Acylated glycerophospholipids and their derivatives. Prog Lipid Res 1990; 29:1-43.
3. Devane W. A., Hanus L., Breuer A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-1949.
4. Johnson D. E., Heald S. L., Dally R. D., Janis R. A. Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding. Prostaglandins Leukot Essent Fatty Acids 1993; 48:429-437.
5. Van Zwieten P. A., Pfaffendorf M. Similarities and differences between calcium antagonists: pharmacological aspects. J Hypertens 1993; 11: S3-S11.
6. 2+ channel. Eur J Pharmacol 1996; 296:347-350.
7. Deutsch D. G., Chin S. A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 1993; 46: 791-796.
8. Hillard C. J., Wilkison D. M., Edgemond W. S., Campbell W. B. Characterization of the kinetics and subcellular distribution of arachidonylethanolamide (anandamide) hydrolase of rat brain. Biochim Biophys Acta 1995; 1257: 249-256.
9. Desarnaud F., Cadas H., Piomelli D. Anandamide amidohydrolase activity in rat brain microsomes. J Biol Chem 1995; 270: 6030-6035.
10. Childers S. R., Sexton T., Roy M. B. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem Pharmacol 1994; 47: 711-715.
11. Edgemond W. S., Campbell W. B., Hillard C. J. The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 83-86.
12. Hillard C. J., Edgemond W. S., Campbell W. B. Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. J Neurochem 1995; 64: 677-683.
13. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-252.
14. I) and the concentration of inhibitor which causes 50 percent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099-3110.
15. Spector A. A. Fatty acid binding to plasma albumin. J Lipid Res 1975; 16: 165-179.
16. 2+) currents in cat cerebral arterial smooth muscle cells. FASEB J 1995; 9: A263.
17. 2+ currents in cat cerebral arterial smooth muscle cells. FASEB J 1996; 10: A302.